Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Join

Subscribe or Register

Existing user? Login

In this issue

Insight

Person's face disintegrating, suicide concept

Suicide and preventionSubscription

In early January 2015, my daughter attended the funerals of two male friends. They didn’t know one another; they lived in different parts of the south of England. Both had committed suicide.

Review

Illustration showing the path of pain and its inhibition at the level of the neurons of the spinal cord

Treatments for neuropathic painSubscription

By ,

Abstract: Neuropathic pain (NP) is a common condition characterised by subjective negative and positive symptoms that range from numbness to debilitating pain. NP can have a significant negative impact on a patient’s quality of life. Pharmacotherapy is typically the first step in treating NP. Guidelines and consensus statements from various organisations around the world appear to be consistent with the classes of medications recommended for both general and specific types of NP, which ...

Short communications

How chemotherapy and radiation lead to intergenerational impact on fertilitySubscription

By

On 31 October 2017, at the American Society for Reproductive Medicine in San Antonio, Patel and colleagues presented the first study to correlate chemotherapy-treated women with reduced fertility of their offspring

Survey of oncology healthcare professionals demonstrates inadequate reference information sources used for prescribingSubscription

We wish to highlight to readers of Clinical Pharmacist, the results of a recent survey of oncology healthcare professionals (HCPs) which demonstrated that inadequate and potentially out-of-date sources of information may be used as reference sources for prescribing medicines in oncology. Use of outdated reference sources has implications for patient safety, potentially exposing patients to risk.

Research briefing

MRI scan of brain with multiple sclerosis

Antihistamine shows potential to repair neuron damage in multiple sclerosisSubscription

20 NOV 2017

Research shows an over-the-counter antihistamine could act as a remyelinating agent in multiple sclerosis

Close up of woman receiving botox injection

Botox more effective than topiramate for chronic migraine preventionSubscription

20 NOV 2017

New research suggested botox had greater tolerability compared with topiramate against chronic migraine

Micrograph of H1N1 virus

H1N1 infection may increase risk of type 1 diabetesSubscription

20 NOV 2017

Researchers from Norway used national registry data to explore if the H1N1 virus could be linked to the development of type 1 diabetes

Close up of man's hands holding a vape

Replacing cigarettes with vaping could cut early deathsSubscription

20 NOV 2017

Researchers modelled a hypothetical scenario where 95% of smokers in the United States switched to e-cigarettes over a 10 year period

Clinical Pharmacist

cover cp 299 7908 17

CP December 2017, Vol 9, No 12

Cover Story:

Treatments for neuropathic pain

Read more…

Clinical Pharmacist

View previous issue

Clinical Pharmacist is a monthly, peer-reviewed journal that provides authoritative resources on the clinical management of disease in relation to medicines and up-to-date information about advances in pharmacy and drug development. Clinical Pharmacist publishes Review articles, Perspectives, evidence-based CPD articles and Research articles on topics from drug discovery to clinical pharmacology and pharmacy.

The international audience of Pharmaceutical Journal Publications consists of pharmacists, pharmaceutical scientists and healthcare professionals. The journal is available to 44,000 members of the Royal Pharmaceutical Society, as well as non-member individual subscribers and subscribing institutions.